VAERS Explorer
Back to explore

Report #2863654

Received Oct 7, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
MI
Recovered
Unknown
Vaccinated
Sep 16, 2025
Onset
Sep 16, 2025
Days to onset
0
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNKY015180—
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNKZ007940—
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKZ005232—

Symptoms (3)

Extra dose administeredNo adverse eventProduct preparation issue

Symptom narrative

No reported side effects/symptoms from the patient at time of call. No additional AE details provided. No additional AE reported.; Caller reports this occurred due to her removing the label from the GARDASIL 9 and then when she went to reconstitute the VARIVAX she had forgotten that she had done this and grabbed it because she thought it was diluent.; Inbound call from medical assistant who reports she inadvertently administered VARIVAX that was reconstituted with GARDASIL 9 instead of diluent to a patient. She also administered an additional dose GARDASIL 9 to this patient.; Caller reports this occurred due to her removing the label from the GARDASIL 9 and then when she went to reconstitute the VARIVAX she had forgotten that she had done this and grabbed it because she thought it was diluent.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 16-Sep-2025, the reporter inadvertently administered the varicella virus vaccine live (Oka-Merck) (VARIVAX) (lot #Z005232, expiration date: 27-Feb-2027) that was reconstituted with human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) (lot #Y015180, expiration date: 28-Jan-2027) instead of diluent to the patient. She also administered an additional dose human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) (lot #Z007940, expiration date: 05-Mar-2026) to this patient (Accidental overdose). This occurred due to her removing the label from the human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9), and then when she went to reconstitute the varicella virus vaccine live (Oka-Merck) (VARIVAX) she had forgotten that she had done this and grabbed it because she thought it was diluent (Product preparation issue). No reported side effects/symptoms from the patient at time of call as patient has left the office and medical assistant realized after (No adverse event).